Therefore, in this study, we developed an aptamer-based strategy for use as a molecular inhibitor of RAGE/NFκB/VEGF-A axis for suppression of inflammatory-induced angiogenesis associated with colorectal cancer progression. This evidence concerns the gene NFKB1 and colorectal cancer.